Skip to content

Clinical trials

Phase 1/2 Myotonic Dystrophy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myotonic Dystrophy Phase: Phase 1/2 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20141
20211
20221
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting2
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARTHEx Biotech S.L.1
Avidity Biosciences, Inc.1
Dyne Therapeutics1
Ionis Pharmaceuticals, Inc.1
Sanofi1
Sarepta Therapeutics, Inc.1
University of Rochester1
Vertex Pharmaceuticals Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myotonic Dystrophy8
Myotonic Disorders2
Neuromuscular Diseases2
Genetic Diseases, Inborn1
Heredodegenerative Disorders, Nervous System1
Muscular Diseases1
Muscular Disorders, Atrophic1
Muscular Dystrophies1
Musculoskeletal Diseases1
Myotonia1

Trials

Showing 76 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.